How Does Lithium Carbonate Work? Mechanism of Action Explained in Plain English

Lithium Carbonate has been prescribed for bipolar disorder for more than 70 years. It is listed on the WHO's list of Essential Medicines and is recommended as first-line treatment by nearly every major psychiatric guideline. Yet one of the most surprising facts about lithium is this: we still don't fully understand exactly how it works.

The FDA-approved labeling for Lithium Carbonate states plainly: "The mechanism of action of lithium as a mood stabilizing agent is unknown." And yet it reliably stabilizes mood in bipolar disorder. Here's what scientists have figured out so far—and why the full picture remains one of psychiatry's most interesting open questions.

What We Know: Lithium Is an Element, Not a Complex Chemical

Lithium (Li) is the third lightest element on the periodic table—just after hydrogen and helium. It is a naturally occurring alkali metal. Lithium Carbonate (Li₂CO₃) is simply lithium combined with a carbonate to make a stable, dissolvable salt that can be taken orally. Once absorbed in your intestines, it dissociates into the lithium ion (Li⁺), which enters your bloodstream and crosses into your brain.

Because lithium is so simple chemically, it interacts with multiple systems in the brain rather than targeting a single receptor—like a key that works in many locks. This broad action profile may explain both its effectiveness and its wide range of side effects.

Theory 1: Lithium Alters Sodium Transport in Neurons

The earliest and best-established observation is that lithium alters sodium transport across nerve cell membranes. Neurons communicate by generating electrical signals—action potentials—that depend on the movement of sodium (Na⁺) ions through the cell membrane. Lithium ions (Li⁺) are similar enough to sodium ions that they can enter neurons through the same channels. Once inside, lithium disrupts normal sodium balance and shifts how catecholamine neurotransmitters (like dopamine and norepinephrine) are metabolized within the cell.

Theory 2: Lithium Boosts Serotonin

Laboratory studies using rat brain cells (serotonergic neurons from the raphe nuclei) have shown that lithium enhances serotonin release during neuronal activity. This pro-serotonergic effect may contribute to both lithium's antidepressant augmentation properties and its unique anti-suicidal effects—since lower serotonin activity is associated with impulsivity and suicidal behavior. Lithium appears to increase serotonin synthesis by neurons, rather than blocking its reuptake (as SSRIs do).

Theory 3: GSK3-Beta Inhibition and Neuroprotection

One of the most studied molecular mechanisms of lithium involves an enzyme called GSK3-beta (glycogen synthase kinase 3-beta). Lithium both directly and indirectly inhibits GSK3-beta. Here's why that matters:

GSK3-beta is involved in regulating mood, circadian rhythms, neuroplasticity (how neurons adapt and strengthen), and cell survival.

When GSK3-beta is overactive (as may occur in bipolar disorder), it contributes to neuronal damage and mood dysregulation.

By inhibiting GSK3-beta, lithium activates the mTOR pathway, which promotes neuroprotective and cell-survival effects.

This neuroprotective effect may explain one of lithium's most remarkable findings: long-term lithium users show greater brain gray matter volume—particularly in the prefrontal cortex and hippocampus—compared to bipolar patients not on lithium. These brain regions are critical for emotional regulation and memory. There is also evidence that lithium reduces the risk of dementia by approximately 50% in people with bipolar disorder.

Theory 4: Effects on the Inositol Signaling Pathway

Lithium also inhibits an enzyme called inositol monophosphatase (IMPase), which is involved in the recycling of inositol—a molecule important for the phosphatidylinositol (PI) signaling pathway inside neurons. This pathway is involved in how neurons respond to neurotransmitters. The "inositol depletion hypothesis" of lithium's action, proposed in the 1980s, suggests that by depleting inositol, lithium reduces overactive neural signaling in bipolar disorder—essentially acting as a brake on overstimulated circuits.

Why the Full Mechanism Remains Unknown

The challenge with lithium is that it interacts with multiple systems simultaneously. It affects sodium channels, serotonin, norepinephrine, GSK3-beta, the mTOR pathway, the inositol pathway, and possibly others not yet characterized. In most drugs, we can point to one mechanism ("it blocks dopamine D2 receptors" or "it inhibits serotonin reuptake"). With lithium, the full picture is a network of effects, and it is unclear which of these is the primary driver of mood stabilization.

What is clear is the outcome: lithium works. Its efficacy for bipolar disorder is among the most robust in all of psychiatry, with more than 70 years of clinical evidence, multiple Cochrane reviews, and guideline endorsements worldwide. Sometimes in medicine, the evidence of benefit precedes our understanding of mechanism—and lithium is the prime example.

For a comprehensive overview of lithium's uses and dosing, see What Is Lithium Carbonate? Uses, Dosage, and What You Need to Know in 2026. For information on side effects, see Lithium Carbonate Side Effects: What to Expect and When to Call Your Doctor.